abstract |
The present invention provides novel substituted heptadeca-5,9- and 5,10-dienoic acid and similar fatty acid compounds which are derivatives of certain prostaglandins and are potent thromboxane A 2 inhibitors. By virtue of this pharmacological property, they represent useful pharmacological agents for a wide variety of purposes. |